genprowebdirectory
Skip to content
Facebook
LinkedIn
RSS
Twitter/X
YouTube
GEN Edge
Featured News
Multimedia
Content
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits & Spotlights
Webinars
GEN Live
Learning Labs
Podcasts
Videos
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Toggle Search
Search for:
Search
Search
Toggle Mobile Menu
Toggle Search
×
GEN Edge
Expand submenu
Featured News
Multimedia
Content
Expand submenu
News
Insights
Topics
Expand submenu
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Expand submenu
Browse Issues
Subscribe
Multimedia
Expand submenu
Summits & Spotlights
Webinars
GEN Live
Learning Labs
Podcasts
Videos
Resources
Expand submenu
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
Expand submenu
GEN Biotechnology
Re:Gen Open
New Products
Subscribe
Expand submenu
Get GEN Magazine
Get GEN eNewsletters
×
Search for:
Search
Search
Home
>
Topics
>
OMICs
>
Frank Slack, Ph.D.
Frank Slack, Ph.D.
July 27, 2006
– from Yale University talks with GEN’s Editor-in-Chief John Sterling about microRNAs.
/wp-content/uploads/2018/09/gc_4.mp3
Podcasts
Resources
Biomarkers
Cancers
Cellular, Molecular and Developmental Biology
Diagnosis
Medicine, Diagnosis, and Therapeutics
miRNA (Nucleic acids)
Molecular biology
Nucleic acids
RNA
Systemic conditions
Also of Interest
FDA to Highlight Aging, Longevity Medicine in Planned FARS Updates
Microbiome Patterns Vary Among Individuals with Different Cancer Types and Onset Age
AI and Proteomics Accelerate VAV1 Molecular Glue Discovery
Merck, SciBrunch Launch Up-to-$2.13B Collaboration to Develop Preclinical KRAS-Inhibiting Molecular Glue
Cell Senescence 'Barcodes' Identified with Raman Microscopy and Gene Expression Data
StockWatch: Novo's 2030 Strategy Underwhelms Investors at Capital Markets Day
Related Media
AACR 2026: A Video Update from San Diego
AI in Protein Design: Hype vs. Reality Explained by David Baker
AACR 2025: A Video Update from Chicago
Avak Kahvejian, PhD, Recounts His Journey from Sequencing Pioneer to Flagship General Partner on "Close to the Edge"
AACR 2024: A Video Update from San Diego
Celebrating DNA: Matthew Cobb's Reflections on the Double Helix